Register for Upcoming Webinar on DEC. 8 @ 11AM

2023 China NMPA Bluebook is here:

China Market Flash: Venus Medtech Acquires InterValve


Venus Medtech

China’s Venus Medtech acquired U.S. company InterValve to create a systematic TAVR treatment and strengthen its global expansion.

Venus Medtech announced in this month that it has purchased U.S. Company InterValve, the supplier of balloon aortic valvuloplasty products, and that the relevant delivery procedures have been completed recently.

China Med Device, LLC, specializing in providing turn-key solutions for medtech companies‘ entry into China, brings you up-to-date information on China’s medtech and medical device market. Contact our team at or visit us at We can help you tap into the fast-growing China market and accelerate your product’s entry.

Have Questions?

Related Services


Recent Events

Related Posts


Get Updated

Receive Updates in Your Inbox